Early pregnancy screening, before 15 GW, is aimed at detecting abnormal glucose metabolism as higher values may increase the risk of adverse pregnancy and neonatal outcomes, increase the need for insulin therapy, or lead to a later diagnosis of GDM. The gene discussed is INS; the disease is gestational diabetes.